Alsaid, Hasan
GlaxoSmithKline (United States)
2 papers on CoChatORCID 0000-0001-6600-2146
Most cited papers
- Verified
Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity
Atkins, C., Liu, Q., Minthorn, E., Zhang, S.-Y., Figueroa, D. J., Moss, K., Stanley, T. B., Sanders, B., Goetz, A., Gaul, N., et al. (2013) · Cancer Research
Endoplasmic Reticulum Stress and DiseasePI3K/AKT/mTOR signaling in cancer
Cited by 443
- Verified
An Orally Active TRPV4 Channel Blocker Prevents and Resolves Pulmonary Edema Induced by Heart Failure
Thorneloe, K. S., Cheung, M., Bao, W., Alsaid, H., Lenhard, S., Jian, M.-Y., Costell, M., Maniscalco-Hauk, K., Krawiec, J. A., Olzinski, A., et al. (2012) · Science Translational Medicine
Ion Channels and ReceptorsTakotsubo Cardiomyopathy and Associated Phenomena
Cited by 337
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free